The human ovarian surface epithelium (hOSE) is a squamous-to-cuboidal layer that surrounds the ovary. hOSE undergoes injury and repair cycles as a result of ovulation-induced inflammation, an event relevant to the development of epithelial ovarian cancer (EOC). Locally produced steroids mediate the response to inflammation. 3b-Hydroxysteroid dehydrogenase (3b-HSD) drives the intracrine generation of progestogens and androgens that potentially affect cell survival and proliferation. We therefore investigated the regulation of 3b-HSD along with downstream steroid signalling in hOSE. Double immunofluorescence of cultured primary hOSE cells confirmed the expression of 3b-HSD protein Interleukin (IL). IL-1a treatment of primary cells to mimic ovulation-associated inflammation suppressed 3b-HSD1 expression and stimulated 3b-HSD2 mRNA (P , 0.001), without affecting total 3b-HSD protein and activity or androgen or progesterone receptor (PR) mRNA levels. Conversely, IL-4 as a proxy for a post-ovulatory healing cytokine increased both 3b-HSD transcripts, total protein and activity (P , 0.01). IL-4 also suppressed androgen receptor expression (P , 0.01) without affecting that of the PR, thereby potentially sustaining both progesterone biosynthesis and its underlying signalling in the ovarian surface. 3b-HSD protein was immunodetectable in primary ascites of women who were diagnosed with EOC but both mRNA transcripts were diminished relative to normal cells (P , 0.05). Notably, this difference was countered by IL-4 treatment (P , 0.01). We conclude that stimulation by IL-4 could be physiologically relevant to post-ovulatory ovarian healing and suggest a novel therapeutic strategy for the activation of progesterone-associated apoptosis in ovarian cancer. Also, our results suggest an attenuation of 3b-HSD expression in EOC although further studies are required for confirmation.
Introduction
The human ovarian surface epithelium (hOSE) is a squamous-tocuboidal cellular monolayer of mesodermal origin that lines the ovary (Gillett et al., 1991) . Interest in hOSE arises from the widely held belief that .85% of ovarian cancers are epithelial ovarian cancers (EOCs) Runnebaum and Stickeler 2001) . At least three interrelated but not mutually exclusive hypotheses have been advanced to explain the development of EOC. Natural reproductive events such as ovulation, accompanied by inflammation and fuelled by pre-and post-ovulatory reproductive hormones (i.e. gonadotrophins, estrogens, androgens, progesterone) are believed to have a role in the aetiology of EOC (Fathalla, 1971; Cramer and Welch, 1983; Espey, 1994; Risch, 1998; Ness and Cottreau 1999) . Ovulation resembles a controlled acute inflammatory reaction (Espey, 1980) , involving inflammatory mediators and proteases necessary for follicular rupture and post-ovulatory remodelling (Bonello et al., 1996; de Visser and Coussens, 2005) . Proteolytic breakdown of the follicle wall and inflammatory necrosis of adjacent surface epithelial cells are followed by re-epithelization and associated susceptibility to DNA damage (Murdoch et al., 1997) . Thus, each ovulatory episode potentially leads to the accumulation of harmful genetic mutations and subsequent neoplastic transformation of hOSE (Ness et al., 2000a, b; Murdoch et al., 2001) . Elucidating the local antiinflammatory steroidal mechanisms that normally protect OSE at ovulation could therefore potentially reveal novel molecular markers for diagnosing or treating ovarian cancer (Rae and Hillier, 2005) .
We previously reported that the OSE expresses notable levels of 3b-hydroxysteroid dehydrogenase (3b-HSD) protein with 3b-HSD1 mRNA predominating over 3b-HSD2 mRNA (Papacleovoulou et al., 2009 ). Most importantly, we also showed differential regulation of mRNA transcripts encoding 3b-HSD1 and 3b-HSD2 isoforms by the pro-inflammatory cytokine IL-1a (Rae et al., 2004b; Papacleovoulou et al., 2009) . Precisely, we showed that IL-1a dose-dependently reduces 3b-HSD1 mRNA and increases 3b-HSD2 mRNA, whereas the T lymphocyte-associated cytokine, IL-4, substantially stimulated both 3b-HSD transcripts in a dose-dependent manner (Papacleovoulou et al., 2009) . In humans, 3b-HSD1 is the product of the HSD3B1 gene, which is mainly expressed in trophoblast, mammary and skin (Thomas et al., 1988 (Thomas et al., , 1989 Rheaume et al., 1991) , whereas 3b-HSD2 (product of the HSD3B2 gene) predominates in gonads and adrenal (Lorence et al., 1990; Rheaume et al., 1991) . The relevant contribution of 3b-HSD1 and 3b-HSD2 expression to 3b-HSD enzymatic activity is unknown, but total 3b-HSD activity in hOSE is expected to determine the availability of anti-inflammatory (Rae et al., 2004a) and apoptotic (Bu et al., 1997; Murdoch and Van Kirk, 2002) progesterone as well as the cytoproliferative androgen (Edmondson et al., 2002) for signalling via nuclear progesterone (PR) and androgen receptors (AR), respectively. In this context, epidemiological and basic studies have linked pregnancy and oral contraception with a reduced risk of emergence of ovarian cancer (Risch et al., 1994; Bu et al., 1997; Rodriguez et al., 1998; Murdoch and Van Kirk, 2002; Rae et al., 2004a) . Moreover, immunodetection of components that promote progesterone biosynthesis and signalling, including steroidogenic acute regulatory protein, 3b-HSD and PR, is correlated with a good prognosis for the disease (Abd-Elaziz et al., 2005) . Therefore, it is important to elucidate the mechanisms that are involved in progesterone pre-receptor metabolism in hOSE and investigate whether these pathways are retained in EOC, in order to propose markers that may aid diagnosis and/or management of the disease.
IL-1a is produced during ovulation and is instrumental to the inflammatory changes associated with follicular rupture (Gerard et al., 2004; Rae et al., 2004a, b) . On the other hand, IL-4 is mainly produced by the progesterone-secreting peri-ovulatory follicle and corpus luteum (Hashii et al., 1998) , suggestive of a role in post-ovulatory repair of hOSE.
Herein, we show that primary cultured hOSE cells express functional 3b-HSD protein and further confirm the expression of both 3b-HSD1 and 3b-HSD2 mRNA. We now establish that 3b-HSD isoforms are differentially regulated by IL-1a without apparently affecting total 3b-HSD protein and activity, thereby resulting in a balance of intracrine steroid biosynthesis during ovulation-associated inflammation. Moreover, IL-4 profoundly induced total 3b-HSD protein and activity and attenuated AR expression levels with no effect on those of PR, suggesting that IL-4 sustains progesterone bioavailability during hOSE wound healing. Finally, although 3b-HSD immunoreactivity is also present in ovarian cancers, relative 3b-HSD1 and 3b-HSD2 mRNA levels are lower than in normal hOSE cells, suggestive of an acquired feature of neoplastic transformation.
Methods

Subjects
The physiology of the ovarian cell surface was studied using primary hOSE cells and ovarian tissue that were obtained from premenopausal women (mean age 36 years) who underwent surgery for benign gynaecological disorders, including fibroids, heavy menstruation and pelvic pain. Subjects with endometriosis or receiving any medication, including oral contraceptives, that could potentially affect ovarian function were excluded. Ovarian surface epithelial cells were 'brushed' from the ovarian surface at an early stage of the surgery to minimize any contamination with blood and stromal cells. The basic clinical profile of these patients is given in Table I . Ovarian cancer cells for in vitro experimentation as well as for histological studies were recruited from post-menopausal and two premenopausal women diagnosed with ovarian cancer (mean age 63 years). Basic clinical information of the ovarian cancer patients is given in Table II . Formal written consent was obtained from all subjects and the project was approved by the Lothian Research Ethical Committee (project numbers 04/S1103/36 and 05/S1103/14 for hOSE cells and 04/S1103/44 for cancer cells). 
Cell lines
Establishment of primary cell monolayers
Primary hOSE cells and primary cancer cells were collected and cultured as described previously (Kruk et al., 1990; Hillier et al., 1998; Dunfield et al., 2002) . Briefly, normal epithelial cell scrapings and ascitic fluid samples were placed into 75 cm 2 donor-calf serum pre-coated flasks (Corning Inc. Glass Works, Corning, NY, USA) containing MCDB 105:M199 culture medium (1:1 v/v), 15% (v/v) fetal bovine serum (FBS), 2 mmol/l L-glutamine, 50 mg/ml streptomycin and 50 IU/ml penicillin (all from Life Technologies, Inc., Paisley, UK and Sigma Chemical Co., Poole, UK). Incubations were in a humidified tissue culture incubator gassed with 95% air -5% CO 2 at 378C. Medium was refreshed every 7 days and cells reached confluence between 2 and 4 weeks (Hillier et al., 1998) . These culture conditions do not allow the growth of immune cells or cell contaminants which could interfere with the primary ascites cells (Dunfield et al., 2002) . The purity of hOSE and ovarian cancer cells was confirmed by phase-contrast microscopy, and in selective cases, by immunohistochemical staining for epithelial-specific cytokeratin markers (van Niekerk et al., 1991; Auersperg et al., 2001; Rae et al., 2004b) . After establishment of confluent cellular monolayers, cells were detached by incubation at 378C in 5 ml trypsin/EDTA (Sigma) in HBSS (0.05% w/v trypsin, 0.5 mM EDTA). The resultant cell suspension was washed with DPBS and centrifuged twice before reconstitution into 1 ml pre-warmed culture medium followed by cell counting using a haemocytometer. Viability was assessed by trypan blue (Sigma) dye exclusion and ranged between 80 and 95%.
Establishment of cell-line monolayers
Cell lines were cultured as primary cells with minor modifications. Cells were grown in T162 (Corning) instead of T75 plastic flasks in antibioticfree culture medium that contained 10% instead of 15% FBS. All cell lines were grown in a 95% O 2 /5% CO 2 incubator at 378C with the exception of OSE-C2 cells which were grown at 338C as described previously (Davies et al., 2003; Papacleovoulou et al., 2009) . Culture medium was changed every 3 days and when confluent, cells were passaged as described earlier. Cell viability ranged from 95 to 98%.
Histological studies
Colourimetric immunohistochemistry
Paraffin wax-embedded tissues were cut into 3-mm sections and deparaffinized in xylene, serial dilutions of ethanol, PBS (Sigma, Poole, UK) and distilled H 2 O. Permeabilization was achieved with microwaving, in 0.01 M sodium citrate buffer pH 6.0 (Sigma) for 15 min followed by cooling for a further 20 min. Sequential blocking steps of endogenous peroxidase [3% H 2 O 2 in dH 2 O (v/v); Sigma] and avidin, biotin (Vector, Peterborough, UK) were performed. Each step was followed by PBS washes (2Â). Afterwards, slides were submitted to blocking with non-immune normal goat serum (NGS; Sigma) diluted in PBS (1:5 v/v) containing 5% (w/v) bovine serum albumin (BSA; Sigma) for 20 min followed by overnight incubation with a rabbit polyclonal antibody raised against human recombinant 3b-HSD2 (Thomas et al., 2002) 3b-HSD in human ovarian surface epithelium incubations with goat anti-rabbit or goat anti-mouse biotinylated IgG 1 (Vector) and RTU-ABC elite kit (avidin -biotin complex; HRP conjugated; Vector) were each done for 1 h before washing away excess antibody with PBS supplemented with 0.05% Tween 20 (v/v) (PBST; Sigma). Sections were washed thrice with PBST between steps. Finally, slides were incubated with HRP-conjugated diaminobenzidine (DAB; Vector) chromagen for 5 min, and after haematoxylin counterstaining, dehydrations in serial ethanol dilutions (50 -100%) and xylene were conducted. Antral ovarian follicles served as positive controls for 3b-HSD (Suzuki et al., 1993) . The immunostained sections were visualized with an Olympus Provis microscope (Olympus Optical, London, UK).
Fluorescent immunohistochemistry
Cells were passaged into eight-well glass chamber slides (Nunc Lab-Tek, Leicestershire, UK) at a density of 25 000 cells/well and incubated at 378C/5% CO 2 for 24 h. Following serum-starvation overnight with medium containing 0.01% BSA (Sigma) instead of FBS, cells were fixed in 100% ice-cold methanol at 2208C for 10 min followed by permeabilization with ice-cold acetone at 2208C for 1 min. Sections of ovarian tissues and freshly isolated ascites pellets were processed as stated earlier with minor modifications. Incubation with 3b-HSD antibody or unconjugated rabbit IgG 1 antibody (negative control) diluted in 1:400 in NGS/PBS/BSA preceded immunodetection with goat anti-rabbit IgG 1 antibody directly conjugated to Alexa Fluor 546 (1:200 in PBS; Molecular Probes, Poort Gebouw, The Netherlands), which provides red fluorescent positive staining. After non-immune blocking, incubation with the antihuman mouse monoclonal cytokeratin 7 antibody at 48C overnight (1:300 in NGS/PBS/BSA) followed by immunodetection with goat antimouse IgG 1 antibody conjugated to Alexa Fluor 488 (1:200 in PBS, Molecular Probes) was performed to yield green fluorescent cytokeratinpositive staining. Slides were counterstained with a nuclear-specific blue fluorescent label, 4,6-diamidino-2-phenylindole (DAPI; Sigma) in 1:1000 dilution in PBS. Mounting was achieved with Permafluor Aqueous Medium (Beckman Coulter, High Wycombe, Buckinghamshire, UK). Images were captured with Zeiss LSM 510 Meta Axiovert 100M confocal microscope (Carl Zeiss Ltd, Welwyn Garden City, UK) at Â40 magnification.
Experimental treatments of hOSE and cancer cells
Cell suspensions were adjusted to 3.5 Â 10 5 viable cells per well of 6-well culture plates for mRNA and protein studies or 10 5 viable cells per well of 12-well plates for 3b-HSD activity assay (Corning). Following cell monolayer establishment (24 h), medium was replaced with serum-free medium for 24 h. Cells were exposed to 0.02 or 0.5 ng/ml of IL-1a or IL-4 (R&D Systems, Abingdon, Oxon, UK) (all in serum-free medium) for 12, 24 and/or 48 h. At all experimental time-points, cells receiving no treatment were used as controls.
RNA purification and quantity analysis
Cell monolayers in six-well plates were washed twice with DPBS. Cells were lysed by re-suspension in 0.35 ml guanidine thiocyanate-containing buffer (RLT lysis buffer; Qiagen, West Sussex, UK) supplemented with 0.01% (v/v) b-mercaptoethanol (Sigma) and vigorous vortexing. Lysates were then processed for RNA purification using the RNeasy Mini kit (Qiagen) as per manufacturer's guidelines. To preclude genomic contamination, DNaseI digestion was performed using the Qiagen RNase-free DNase set, on-column, during RNA purification. Purified RNA (1.5 ml) was quantified using a Nanodrop spectrophotometer (ND-1000, Nanodrop Technologies Inc., Wilmington, DE, USA), with purity ascertained by the 260/280 and 260/230 ratios (above 2.0).
Taqman real-time quantitative PCR mRNA analysis
Two-step Taqman quantitative PCR (qPCR) was performed to measure the levels of 3b-HSD1, 3b-HSD2, PR, AR and IL-4 receptor (IL-4R) mRNA in treated and untreated hOSE and cancer cell samples. Using a first-strand cDNA synthesis kit (Applied Biosystems, Applera, Warrington, UK), DNase-treated RNA was reverse-transcribed to cDNA using random hexamer priming system in a 10 ml reaction mixture as per supplier's guidelines. cDNA (2 ml) was used for qPCR, using commercial Applied Biosystems reagents. Each reaction was carried out in duplicate. Primer/probe sets for 3b-HSD1, 3b-HSD2 and IL-4R mRNA transcripts were pre-validated (Assay-on-Demand, Applied Biosystems), whereas those for AR and PR were designed using the Primer-Express software (Perkin-Elmer, Beaconsfield, Bucks, UK). Nucleotide sequences are illustrated in Table III . 18S ribosomal RNA served as internal control for each individual sample. Mean values reflecting the PCR cycle when the target transcript started to be accumulated relative to 18S (mean dC T in a 40 cycle PCR reaction) are given in Table IV . Values of more than 36 out of 40 PCR cycles were assessed as beyond the limit of robust detection; however, they were included in analysis for comparison reasons. Taqman reactions were performed in an ABI Prism 7900 Sequence Detector (Applied Biosystems).
Western immunoblotting
hOSE cell monolayers were washed with cold PBS and lysed in 50 mM Tris -HCl, pH 7.6, 0.1% SDS, 1% deoxycholate (all from Sigma) containing a cocktail of proteinase inhibitors (Roche Diagnostics Gmbh, Manheim, Germany). Cell extracts were then prepared by sonication. Total protein (25 mg/ml) was size-fractionated by electrophoresis (12% SDS/ PAGE) and transferred to PVDF membrane (Millipore, Bedford, MA, USA) followed by blocking for 2 h in 5% dried semi-skimmed milk diluted in PBST. Overnight incubation at 48C with anti-human rabbit 3b-HSD (1:20 000) or with anti-human rabbit AR (1:1000) or anti-human rabbit actin (1:1000; Abcam, Cambridge, UK) diluted in 1% dried semiskimmed milk/PBST was followed by a 1-h incubation with goat anti-rabbit IgG 1 conjugated to HRP (Sigma) in 1:10 000 in 1% milk/PBST. Proteins were detected by the ECL detection kit (Millipore). Human placenta (Thomas et al., 1988 (Thomas et al., , 1989 and human H295 adrenocortical cells (Rainey et al., 1994) were used to ascertain that the 3b-HSD antibody detected both isoforms. The breast cancer T47D cell line was used as positive control for AR (Chalbos et al., 1987; Buchanan et al., 2005) .
3b-HSD activity assay
Pre-cultured cell monolayers were prepared for 3b-HSD enzymatic assay as described previously with minor modifications (Gingras et al., 1999) . Treatment media were removed and replaced with 1-ml fresh serum-free medium containing 0.5 mM pregnenolone (PREG) and 150 000 cpm/ml [ 3 H]-PREG to monitor pregnenolone to progesterone conversion, reflecting 3b-HSD dehydrogenase/isomerase activity. Blank (no-cell) culture wells were treated similarly to establish negative controls. After 8 h incubation, the medium was transferred to tubes containing dichloromethane (8 ml) for the extraction of steroids into the organic phase. Samples were centrifuged at 1000g for 15 min, the aqueous phase removed and the organic phase concentrated under a flow of nitrogen gas. Following reconstitution in 100 ml dichloromethane, samples were applied onto silica gel-pre-coated sheets (PE, SIL G; Whatman, Maidstone, Kent, UK) and chromatographed using chloroform/ethanol (92:8 v/v) as the solvent system. Radiochromatograms were produced using a Bioscan 200 imaging detector (Lablogic Systems, Sheffield, UK 3b-HSD in human ovarian surface epithelium
Statistical analysis
Data sets are presented as means and standard errors (+SEM). Basic statistical analysis was performed using the GraphPad Prism 4.00 software (GraphPad Software Inc., San Diego, CA, USA). Repeated measures ANOVA and Newman -Keuls post hoc testing were run for multiple comparisons, whereas two-tailed paired Student's t-tests were performed for single comparisons. P , 0.05 was taken as significant. All values given in the results and figure legends reflect statistical difference relative to untreated control cells, unless otherwise specified.
Results
Expression of 3b-HSD protein in hOSE
Dual immunoflurescence staining showed that 3b-HSD staining (red) overlapped with epithelial cytokeratin (green) staining in situ in the hOSE layer of whole-ovarian tissue (Fig. 1b-d) . A similar pattern of 3b-HSD immunostaining was observed in 4-week-old cultured hOSE cell monolayers (Fig. 1f-h ). Follicular cells were also positive for 3b-HSD with an intense staining in theca interna cells (Fig. 1j -l) . Regulation of 3b-HSD1 and 3b-HSD2 mRNA by IL-1a and IL-4 in primary hOSE cells
In order to further evaluate our previous observation that ovarian wounding and post-ovulatory repair involved 3b-HSD (Papacleovoulou et al., 2009), we challenged hOSE cells in a time-course manner with IL-1a (0.5 ng/ml) as a proxy for ovulation-associated inflammation or IL-4 (0.5 ng/ml) as an agent of post-ovulatory repair. Exposure of cultured hOSE cells retrieved from four patients to IL-1a (0.5 ng/ml) for up to 48 h resulted in a progressive and slow reduction of 3b-HSD1 mRNA with an average 8-fold suppression at 48 h ( Fig. 2A upper panel; b: P , 0.001). Simultaneously, IL-1a increased 3b-HSD2 mRNA at least 3-fold from the 12 h time-point with no significant alterations within time ( Fig. 2A lower panel; b: P , 0.001). On the other hand, the same dose of IL-4 on hOSE from three further patients substantially increased both gene products. Time-course studies revealed that the IL-4 effect on both 3b-HSD1 and 3b-HSD2 mRNA levels were maximal by 12 h ( Fig. 2B ; b: P , 0.01; c: P , 0.001).
To further elaborate the differential actions of IL-1a and IL-4, their effects on 3b-HSD1 and 3b-HSD2 mRNA were evaluated in hOSE cells recovered from the same patients. In five out of five patients, IL-1a (0.5 ng/ml, 48 h) suppressed 3b-HSD1 mRNA, whereas IL-4 (0.5 ng/ml, 48 h) massively stimulated 3b-HSD1 mRNA (Fig. 2C left-hand panel) . On the other hand, although IL-1a up-regulated 3b-HSD2 mRNA, its effect was minimal compared with that of IL-4 ( Regulation of 3b-HSD1 and 3b-HSD2 protein and 3b-HSD enzymatic activity by IL-1a and IL-4 in primary hOSE cells Total 3b-HSD protein and enzymatic activity in hOSE cell cultures were unaffected by IL-1a treatment but were increased 3-fold by IL-4 treatment ( Fig. 3 ; n ¼ 7, b: P , 0.001). Dehydroepiandrosterone (DHEA), a substrate for 3b-HSD, showed similar results to those obtained with pregnenolone (data not shown).
Assessment of AR and PR protein and mRNA levels in untreated and cytokine-treated hOSE cells
The presence of AR and PR in hOSE cells was confirmed by immunohistochemistry (IHC) on whole-ovarian sections (data not shown), confirming previously described studies (Edmondson et al., 2002; Li et al., 2003) ; however, reports are lacking on whether these receptors are affected during post-ovulatory injury and repair. AR and PR mRNA expression were sustained in culture but differentially affected by treatment with IL-1a and IL4. Thus, whereas IL-1a did not affect AR or PR mRNA levels (Fig. 4 upper and lower panels, respectively) , IL-4 dose-dependently suppressed AR mRNA ( Fig. 5A upper panel ; n ¼ 4, P , 0.01) without affecting PR mRNA at 48 h (data not shown). This response was confirmed in time-dependent studies over 48 h incubation with 0.5 ng/ml IL-4 treatment ( Fig. 5A lower panel; n ¼ 3, b: P , 0.05). This effect was further confirmed at the protein level, although abrogation of AR protein was observed only with exposure of hOSE cells to a high-dose of IL-4 (5 ng/ml) ( Fig. 5B upper blot) .
Expression of 3b-HSD protein and 3b-HSD1 and 3b-HSD2 mRNA in ovarian cancer
The potential involvement of 3b-HSD-associated pre-receptor metabolism in ovarian cancer was assessed in solid ovarian tumours (n ¼ 4) and EOC cells from ascites (n ¼ 3) obtained from individual patients (Fig. 6) . IHC in representative solid ovarian tumours (poorly differentiated and mixed differentiated with mucinous, serous and endometrioid features; Fig. 6A , upper and lower panels, respectively) revealed constant expression of 3b-HSD protein in epithelial cytokeratin-positive cells (Fig. 6A) . In freshly isolated ascites, immunofluorescence evaluation with epithelial cytokeratin 7 (green) and 3b-HSD (red) antibodies was performed in order to investigate whether 3b-HSD was expressed in epithelial cells of malignant origin. The expression of 3b-HSD protein was demonstrated exclusively in cytokeratin-positive cells (Fig. 6Ba-d) and not in other cell contaminants including active mesothelial or immune cells (Fig. 6Be , white arrows). The malignant phenotype of freshly isolated ascites cells was confirmed through haematoxylin and eosin staining where cells were characterized by pleomorphic nuclei and high mitotic count (Fig. 6Bf) . All cancer tissue was dissected and evaluated by a consultant pathologist, and malignancy was confirmed in the respective clinical histopathology reports. 3b-HSD in human ovarian surface epithelium Differential expression of 3b-HSD1 and 3b-HSD2 mRNA in primary hOSE and ascites cells as well as immortalized hOSE and EOC cell lines
Relative expression of 3b-HSD transcripts was quantified by Taqman qPCR in cultured hOSE cells isolated from three separate patients, in ascites cells collected from a further three patients as well as in various cell lines in three independent experiments (Fig. 7) . Both immortalized cell lines (OSE-C2 and hTERT OSE), both EOC cell lines (SKOV-3 and PEO14) and also primary ascites cells had significantly lower expression levels of 3b-HSD1 mRNA relative to cultured hOSE cells ( Fig. 7 upper panel; n ¼ 3, b and c: P , 0.001). Moreover, the immortalized OSE-C2 cell line expressed 3b-HSD1 mRNA at higher levels than primary ascites, hTERT OSE and EOC cell lines ( Fig. 7 upper panel; n ¼ 3, b versus c: P , 0.01). On the other hand, 3b-HSD2 mRNA was immeasurable in all the cell lines tested. Only primary ascites cells were positive for 3b-HSD2 mRNA (Fig. 7 lower panel) .
However, ascites expressed decreased levels of 3b-HSD2 mRNA relative to cultured hOSE cells, although this was only a trend and not determined to be significant ( Fig. 7 lower panel ; n ¼ 3, P ¼ 0.06). Raw dC T values are presented in Table IV .
Isoform expression pattern of 3b-HSD1 and 3b-HSD2 mRNA in primary hOSE and ascites cells
In all hOSE samples tested, there was variability among different patients; however, 3b-HSD2 mRNA was expressed at lower levels than 3b-HSD1 mRNA in all six cases (Fig. 8A upper panel) . On the other hand, there was variability in the pattern of isoform mRNA expression in EOC samples (Fig. 8 centre panel) .
The combined data showed an average 15-fold greater level of 3b-HSD1 than 3b-HSD2 mRNA in hOSE cells ( Fig. 8A lower panel; n ¼ 6, b: P , 0.05). However, any difference in isoform expression pattern was not observed in primary ascites (Fig.8A lower panel) . Quantitative comparisons also showed that 3b-HSD1 mRNA expression was 42 times higher in normal hOSE than in ovarian cancer cells ( Fig. 8A lower graph ; n ¼ 6, b: P , 0.05). 3b-HSD2 mRNA levels in cancer cells were also decreased 5-fold relative to hOSE cells, though this difference was not statistically significant ( Fig. 8A lower graph ; n ¼ 6, P ¼ 0.06). As expected, 3b-HSD2 was undetectable in placental samples, whereas 3b-HSD2 was 70 times higher than 3b-HSD1 in granulosa-lutein cells (Fig. 8B upper and lower panels, respectively).
Regulation of 3b-HSD1 and 3b-HSD2 mRNA by IL-4 in ovarian cancer
Having demonstrated 3b-HSD protein and transcriptional activity in malignant cells, although at lower levels relative to hOSE cells, we examined whether low 3b-HSD1 and 3b-HSD2 mRNA expression Figure 6 Expression of 3b-HSD protein in solid ovarian tumours (A) and ascites (B). (A) Representative solid ovarian tumours showed immunodetection of 3b-HSD protein in ovarian cancer. 3b-HSD protein immunodetection showed the same localization pattern as epithelial-specific cytokeratin 7. Slides incubated with unconjugated rabbit and mouse IgG 1 served as negative controls for 3b-HSD and cytokeratin 7, respectively, and did not interact with DAB (insets). Slides were visualized with Olympus Provis microscope, and pictures were captured with a digital D30 Canon camera in Â40 (left-hand-side of each panel) and Â4 (right-hand-side capture of each panel) magnification. Scale bars represent 50 mm for Â40 and 200 mm for Â4. (B) Representative slide of double-immunofluorescence for co-localization of 3b-HSD (red) and specific epithelial markers (green) in freshly isolated ascites from patients diagnosed with ovarian cancer (a -e). Cytoplasmic staining with epithelial cytokeratin 7 showed that 3b-HSD is present exclusively in epithelial cells (b -d), since cytokeratine 7-negative cells were not immunoreactive with 3b-HSD antibody (white arrows) (e). Nuclei were counterstained with DAPI (blue, a). Haematoxylin and eosin staining (HþE; f) was performed to confirm malignant phenotype of the ascites (scale bar: 50 mm). Pictures were captured with a Zeiss LSM 510 meta-confocal microscope in Â40 magnification (20-mm scale bars).
3b-HSD in human ovarian surface epithelium levels could be increased after the treatment of cultured cells established from cancer ascites samples with IL-4 (0.02 and 0.5 ng/ml) for 48 h. We observed IL-4R mRNA expression in cancer cells at levels similar to those found in normal primary hOSE cells (Fig. 9B) . Also, qPCR studies revealed that IL-4 treatment substantially increased both 3b-HSD1 and 3b-HSD2 mRNA levels on average 96-fold ( Fig. 9B upper graph; n ¼ 3, b: P , 0.01) and 77-fold ( Fig. 9B lower graph; n ¼ 3, b: P , 0.05; c: P , 0.01), respectively. These data demonstrate that aberrant 3b-HSD functionality in cancer can be restored by treatment with IL-4.
Discussion
We demonstrate 3b-HSD gene expression and enzymatic activity in hOSE cells, suggestive of an intracrine role for 3b-HSD activity in determining functional cellular responses mediated by AR and PR. As noted in the Introduction, differential regulation of 3b-HSD1 and 3b-HSD2 mRNA levels in these cells by cytokines was noted in previous studies (Rae et al., 2004b; Papacleovoulou et al., 2009) . We now establish that both 3b-HSD isoforms likely contribute to the levels of enzymatic activity detected in normal hOSE. Both 3b-HSD mRNA are stimulated by IL-4, followed by a substantial increase in total 3b-HSD protein and activity. The same treatment suppresses AR expression without affecting that of PR. We also find that ovarian cancer cells have lower levels of overall 3b-HSD gene expression but this can be restored by exposure to IL-4.
An advantage of our studies is that we have accumulated data based on OSE and cancer cell function in several patients and therefore they are potentially reflective of (patho)physiological functions of hOSE in vivo. Moreover, our cell culture system based on a 2-to 4-week exposure of the cells to FBS-containing medium prior to experimentation was likely to neutralize the effect of reproductive hormones that might be encountered as a result of cell collection at different stages of the menstrual cycle (Yong et al., 2002; Rae et al., 2004a) . Moreover, this culture system was applied to both primary hOSE and cancer cells, and as such, any contribution of the hormonal environment of the cells at the time of collection should be minimal. This appeared essential, since the use of multiple patients to produce enough replicates for each distinct experiment allowed us to overcome restrictions in cell numbers along with limitations in long-term culture of cells from the same subject. We also reinforced these data by the use of various cell lines established from immortalization of primary hOSE (OSE-C2 and hTERT OSE cell lines) or from the ascitic fluid of patients who were diagnosed with EOC (SKOV-3 and PEO14).
The finding that 3b-HSD is expressed in hOSE and co-localizes with epithelial-specific cytokeratin markers establishes our previous studies showing that hOSE is capable of producing PR-and/or AR-activating steroid ligands (Papacleovoulou et al., 2009) . Both AR and PR are expressed along with 3b-HSD in hOSE cells, which agrees with previous studies showing responsiveness of hOSE to androgens and progestogens (Edmondson et al., 2002; Li et al., 2003) . Co-expression of cytokeratins with 3b-HSD in cultured hOSE monolayers implies that hOSE cells keep their epithelial phenotype and capacity to express 3b-HSD in culture, and this allowed us to investigate in vitro the biological functionality of this enzyme in hOSE cell monolayers. 3b-HSD is involved in the biosynthesis of all classic steroid hormones and is essential for tissue homeostasis. This enzyme converts pregnenolone to the potent PR ligand, progesterone and DHEA to the weak AR ligand, androstenedione. Androstenedione can be subsequently reduced to the more potent AR ligand testosterone by 17b-HSD, which is also present in hOSE cells (Rae et al., 2004b) . Therefore, our data support the concept that hOSE possesses the enzyme machinery necessary to actively participate in ovarian steroidogenesis (Rae et al., 2004b) .
3b-HSD protein and transcriptional activity were also found in solid ovarian tumours and epithelial cells of malignant origin. This implies that ovarian tumours have the capacity to locally generate active progestogens and androgens. Importantly, in double-immunofluorescence studies on ascites samples, it was shown that only epithelial cytokeratin 7-immunopositive cells expressed 3b-HSD. This suggests that our 3b-HSD data for primary ascitic cell cultures most likely reflect malignant epithelial cells rather than other cellular contaminants in the cultures such as activated mesothelial cells. Bearing in mind this potential limitation, comparisons of ascites with primary hOSE cells from patients with benign gynaecological disorders established that 3b-HSD mRNA expression is substantially reduced in ovarian cancer cells. Importantly, this observation was also confirmed in the immortalized OSE-C2 and hTERT OSE cell lines as well as in Figure 7 qPCR for 3b-HSD1 and 3b-HSD2 mRNA in primary cell and cell lines. Taqman qPCR was performed to quantify relative levels of 3b-HSD1 (upper panel) and 3b-HSD2 (lower panel) mRNA isoforms in three separate primary hOSE cultures, three ascites cultures from EOC patients as well as in immortalized hOSE and EOC cell lines in three independent experiments. Graphs represent the mean + standard error of data obtained from three independent replicates (n ¼ 3, b and c: P , 0.001; b versus c: P , 0.05).
SKOV-3 and PEO14 EOC cell lines. Collectively, these data suggest attenuation of pre-receptor metabolism in cancer cells relative to normal hOSE, which might be an acquired feature of (pre)-neoplastic transformation.
qPCR was used to further elucidate the pattern of 3b-HSD isoform expression in primary hOSE and ascites cells. As described previously, in hOSE, 3b-HSD1 mRNA predominated over 3b-HSD2 mRNA (Papacleovoulou et al., 2009) , thereby differing from that previously reported for other ovarian compartments, where 3b-HSD2 is the primary isoform expressed (Rheaume et al., 1991) . Preponderance of 3b-HSD1 mRNA in hOSE is notable since 3b-HSD1 has a higher catalytic efficiency than 3b-HSD2 (Rheaume et al., 1991) . Given that hOSE has limited capacity to produce de novo steroids from cholesterol, at least in vitro (Rembiszewska and Brynczak 1985; Rae et al., 2004b) , 3b-HSD1 predominance is consistent with the expression of this isoform in peripheral non-steroidogenic tissues. Unlike hOSE cells, in primary ascites, there was no difference between 3b-HSD1 and 3b-HSD2 mRNA expression levels, although a trend towards increased 3b-HSD1 was noticed. This was probably a result of variability in isoform expression pattern between different patients and the relative small number of the target group.
Both 3b-HSD isoforms are present and regulated in hOSE cells but their relative functional importance has not been distinguished. Exposure of hOSE to pro-inflammatory IL-1a in a time-course mode progressively suppressed 3b-HSD1 mRNA, whereas IL-1a rapidly stimulated 3b-HSD2 mRNA expression. However, total Figure 8 Isoform expression pattern of 3b-HSD1 and 3b-HSD2 mRNA in primary hOSE and ascites cells. (A) Combined data of six separate hOSE samples and six separate ascites cells. Taqman qPCR was applied to measure expression pattern of 3b-HSD1 and 3b-HSD2 mRNA. Graphs represent the mean + standard error of data obtained from six independent replicates (n ¼ 6, b: P , 0.05). (B) Placenta and lutein-granulosa cells were used as positive controls for 3b-HSD1 and 3b-HSD2 mRNA, respectively. IL-4 regulation of 3b-HSD1 and 3b-HSD2 mRNA expression in primary ascites. Cultured ascites cells were treated with 0.02 or 0.5 ng/ml of IL-4 for 48 h as described in Methods. Graphs represent the mean + standard error of data obtained from three individual patients. Upper graph: n ¼ 3, b: P , 0.01; lower graph: n ¼ 3, b: P , 0.05; c: P , 0.01. 3b-HSD in human ovarian surface epithelium 3b-HSD protein and enzymatic levels were apparently unaltered by IL-1a. Collectively, these data imply local maintenance of steroid biosynthesis during ovulation. IL-1a decreased 3b-HSD1 levels, suggesting that the initiation of ovulation requires minimal local steroid biosynthesis. Concomitant IL-1a-induced 3b-HSD2 expression, favouring the synthesis of active ligands for cognate nuclear steroid receptors, could be a functional mechanism to counteract ovulation-associated inflammation and minimize susceptibility of tissue to genetic damage. Androgens such as mibolerone, a synthetic androgen that specifically couples to AR, have been shown to induce cell proliferation and inhibit cell death (Edmondson et al., 2002) , whereas progesterone has been shown to be anti-inflammatory (Rae et al., 2004a) , apoptotic (Bu et al., 1997; Murdoch and Van Kirk, 2002 ) and inhibitory to cell growth (Ivarsson et al., 2001) in hOSE and cancer. Therefore, basal levels of androgen synthesis may be essential for post-ovulatory repair that involves DNA cell proliferation, whereas associated progesterone synthesis might be vital to nullify genetically damaged cells. Intriguingly, IL-1a did not affect AR or PR mRNA expression levels, suggesting a balance not only in steroid biosynthesis as discussed earlier but also in the access of the active ligands to the cognate receptors. Thus, the simultaneous pro-inflammatory and antiinflammatory response of IL-1a to 3b-HSD isoforms with no affect on total 3b-HSD function coupled with the stability of AR and PR expression in response to this stimulus could be an efficient mechanism of hOSE to counteract post-ovulatory inflammation, and could explain in part why ovulation is a scar-free inflammatory reaction.
The 'anti-inflammatory' cytokine IL-4 strongly stimulated 3b-HSD1 mRNA and 3b-HSD2 mRNA as well as total 3b-HSD protein and activity in normal hOSE cells and ovarian cancer cells. IL-4 is a Th-2 cytokine that exerts its effects through coupling to IL-4R. Its multifunctional actions including its role in inflammation have been reviewed (Nelms et al., 1999) . Up-regulation of both 3b-HSD mRNA and activity, enhancing progesterone and androgen biosynthesis, might be part of the in vivo post-ovulatory healing mechanisms of the ovarian cell surface. Concomitantly, IL-4 attenuated AR mRNA and protein, although in a sluggish manner, with no effect on PR, suggesting that IL-4-induced 3b-HSD favours progesterone rather than androgen signalling and this might be a functional local anti-inflammatory mechanism, given the anti-inflammatory and apoptotic effects of progesterone noted earlier. Interestingly, hOSE cells do not have the capacity to secrete IL-4 de novo but they do express high levels of IL-4R (Burke et al., 1996) . The main source of IL-4 secretion in the premenopausal ovary is the peripheral blood mononuclear cells that infiltrate the periovulatory follicle and later the corpus luteum. IL-4 is highly up-regulated at the luteal phase of the menstrual cycle when progesterone is also abundant (Hashii et al., 1998) . Accordingly, during the progestogenic luteal phase, OSE cells stop proliferating, and genetically scarred cells become committed to death pathways (Murdoch and Van Kirk, 2002) . Collectively, IL-4 secretion increases at the peri-ovulatory follicle and the progestogenic corpus luteum post-ovulatory. Therefore, elevated IL-4 acts in the 3b-HSD of hOSE in a paracrine manner, thereby inducing progesteroneassociated death pathways to secure proliferation of only genetically integral cells for successful repair of the stigma. It is also interesting that IL-4 levels are increased in the corpus luteum of pregnancy (Hashii et al., 1998) , which is consistent with the protective role that pregnancy and multiparity have against ovarian cancer (Adami et al., 1994) .
The low levels of 3b-HSD expression in ovarian cancer cells and the striking restoration of 3b-HSD1 and 3b-HSD2 mRNA levels by IL-4 in cells of malignant origin are consistent with an anti-tumorigenic role for this cytokine in ovarian cancer. We note that an anti-tumour role of IL-4 in breast cancer has been also demonstrated (Gingras Figure 9 (A) Relative expression of IL-4R mRNA between hOSE and ascites. Basal transcriptional levels were measured in primary hOSE and ascites cell monolayers. Graphs represent the mean + standard error of data obtained from six individual patients in each group. (B) IL-4 regulation of 3b-HSD1 and 3b-HSD2 mRNA expression in primary ascites. Cultured ascites cells were treated with 0.02 or 0.5 ng/ml of IL-4 for 48 h as described in Methods. Graphs represent the mean + standard error of data obtained from three individual patients. Upper graph: n ¼ 3, b: P , 0.01; lower graph: n ¼ 3, b: P , 0.05; c: P , 0.01. Nagai and Toi, 2000) . IL-4 has consistently been reported to attenuate the expression of TNF-a-and IL-1a-related pro-inflammatory effects in the TNF-a transgenic mice (Bessis et al., 1998) . Similar to hOSE cells, cancer cells do not secrete IL-4 de novo either but they are positive for IL-4R (Burke et al., 1996) . Importantly, we did not observe any differences in IL-4R mRNA expression levels between cancer and hOSE cells, suggesting that the absence of the ligand and not the receptor is associated with tumorigenesis. Consistently, serum IL-4 levels have been shown to be reduced in post-menopausal women (Kumru et al., 2004) , a stage of life where EOC is most common. It is highly possible, therefore, that IL-4-increased 3b-HSD in favour of local progesterone signalling in hOSE is lost after the menopause. This could have profound implications for the development of post-menopausal ovarian cancer and deserves further investigation. Moreover, it has been reported that estrogens can increase interferon-g (Th-1 response), resulting in the lack of an increase in serum IL-4 levels (Th-2 response) (Kumru et al., 2004) . It is therefore of interest that a positive correlation exists between estrogens and ovarian cancer Mukherjee et al., 2005; Beral, 2007) .
In summary, we demonstrate the expression and functionality of 3b-HSDs during wound-healing cycles of hOSE. Pro-inflammatory IL-1a does not affect total 3b-HSD, AR and PR expression, attesting to a balance in the intracrine steroid biosynthesis and access of the active ligands to cognate receptors, and this could contribute to the integrity of the ovarian cell surface after post-ovulatory injury. On the other hand, IL-4 can stimulate 3b-HSD expression levels, potentially triggering steroid production in the ovarian milieu and also can suppress AR expression, thereby sustaining just the apoptotic and antiinflammatory progesterone action. Moreover, IL-4 can counteract attenuated 3b-HSD expression in ovarian cancer. IL-4-increased 3b-HSD could therefore be a critical determinant of progesterone bioavailability and anti-tumorigenic signalling via PR during ovulatory menstrual cycles, with potential application to the treatment of EOC.
